New: rivaroxabanAll contenthive-129948hive-196917krzzanhive-185836hive-183959hive-166405steemhive-150122photographyhive-180932hive-101145hive-183397hive-144064uncommonlabhive-188619hive-184714bitcoinkrsuccesshive-103599hive-145157hive-193637hive-179660hive-193186hive-180301TrendingNewHotLikersrkmarketresearch (0)in rivaroxaban • 6 years agoRivaroxaban Industry 2019 Market Size, Trends, Growth and Forecast Analysis ReportThe worldwide market for Rivaroxaban is expected to grow at a CAGR of roughly 9.4% over the next five years, will reach 10100 million US$ in 2024, from 5860 million US$ in 2019, according to a new…pareeshphulkar (0)in rivaroxaban • 6 years agoRivaroxaban Market to Surpass US$ 7.0 Billion by 2026Rivaroxaban is a Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) that is marketed as Xarelto. Anticoagulant medicines are potent therapeutic agents used in the prevention or treatment of serious…